Keith Buszek

Keith Buszek is a Professor in the Department of Chemistry at the University of Missouri–Kansas City (UMKC), School of Science and Engineering. He has held faculty positions at Kansas State University, UC Berkeley, Brown University, and the University of Kansas, and was a co-founder and senior investigator at the NIH Center of Excellence in Chemical Methodology and Library Development (KU-CMLD).

His educational background includes:

• B.S. in Chemistry/Biology, University of California, Irvine (1987)
• Ph.D. in Organic Chemistry, University of California, Los Angeles (1990)
• Postdoctoral Fellow, Harvard University (1990–1993)

Dr. Buszek's research focuses on the discovery and development of practical, scalable synthetic routes to biologically relevant natural products, with applications in drug discovery and clinical therapeutics. His work spans medicinal and pharmaceutical chemistry, total synthesis, reaction methodology development, library synthesis, and computational organic chemistry. The research is highly interdisciplinary and collaborative, aiming to advance human and veterinary medicine.

The most recent publications highlight a strong focus on indole aryne chemistry, particularly in cycloaddition and cross-coupling reactions for synthesizing complex heterocyclic systems. These studies integrate experimental and theoretical approaches, with applications in anticancer agents and scalable synthesis of natural product analogs. The work demonstrates a consistent theme of innovation in synthetic methodology with therapeutic relevance.

Dr. Buszek has received numerous awards for research, teaching, and service, though specific names are not listed in the text.

He has trained over 50 postdoctoral researchers and graduate students and secured over $20 million in research funding. He is also the founder or co-founder of several biotechnology or chemistry-related companies, reflecting his translational and entrepreneurial impact. His lab operates at the intersection of fundamental organic chemistry and applied drug development.

Dr. Buszek leads an active research group at UMKC, where his laboratory pursues innovative synthetic strategies and collaborates on interdisciplinary projects in medicinal chemistry and chemical biology.